[Federal Register Volume 85, Number 39 (Thursday, February 27, 2020)]
[Notices]
[Pages 11454-11455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03834]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Tiered Pharmacy Copayments for Medications; Calendar Year 2020
Update
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) Notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT: Joseph Duran, Office of Community Care
(10D), Veterans Health Administration (VHA), Department of Veterans
Affairs, Ptarmigan at Cherry Creek, Denver, CO 80209;
[email protected]; telephone: (303) 370-1637 (this is not a toll-
free number).
SUPPLEMENTARY INFORMATION: Section 17.110 of Title 38 CFR governs
copayments for medications that VA provides to Veterans. Section 17.110
provides the methodologies for establishing the copayment amount for
each 30-day or less supply of medication provided by VA on an
outpatient basis (other than medication administered during treatment).
Tier 1 medication means a multi-source medication that has been
identified using the process described in paragraph (b)(2) of this
section. Not less than once per year, VA will identify a subset of
multi-source medications as Tier 1 medications. Only medications that
meet all of the criteria in 38 CFR 17.110(b)(2)(i), (ii), and (iii)
will be
[[Page 11455]]
eligible to be considered Tier 1 medications; and only those
medications that meet all of the criteria in paragraph (b)(2)(i) of
this section will be assessed using the criteria in paragraphs
(b)(2)(ii) and (iii).
Based on the methodologies set forth in Sec. 17.110, this Notice
updates the list of Tier 1 medications for Calendar Year 2020. The Tier
1 medication list is posted on VA's Community Care website at: https://www.va.gov/COMMUNITYCARE/revenue_ops/copays.asp under the heading
``Tier 1 Copay Medication List.''
The following table is the Tier 1 Copay Medication List that is
effective January 1, 2020 and will remain in effect until December 31,
2020.
------------------------------------------------------------------------
Condition VA product name
------------------------------------------------------------------------
Arthritis and Pain........................... Aspirin Buffered Tablet,
Aspirin Chewable Tablet,
Aspirin Enteric Coated
Tablet, Allopurinol
Tablet, Celecoxib
Capsule, Diclofenac
Tablet, Ibuprofen
Tablet, Meloxicam
Tablet, Naproxen Tablet.
Blood Thinners and Platelet Inhibitors....... Clopidogrel Bisulfate
Tablet, Warfarin Sodium
Tablet.
Bone Health.................................. Alendronate Tablet.
Cholesterol.................................. Atorvastatin Tablet,
Gemfibrozil Tablet,
Lovastatin Tablet,
Pravastatin Tablet,
Rosuvastatin Calcium
Tablet, Simvastatin
Tablet.
Dementia..................................... Donepezil Tablet.
Diabetes..................................... Glimepiride Tablet,
Glipizide Tablet,
Metformin Hydrochloride
(HCL) Tablet, Metformin
HCL 24-hour Sustained
Action (SA) Tablet,
Pioglitazone HCL Tablet.
Dizziness (Vertigo).......................... Meclizine HCL Tablet,
Meclizine HCL Chewable
Tablet.
Electrolyte Supplement....................... Potassium SA Tablet,
Potassium SA Dispersible
Tablet.
Gastrointestinal Health...................... Omeprazole Enteric Coated
(EC) Capsule,
Pantoprazole Sodium EC
Capsule, Ranitidine
Tablet.
Glaucoma and Eye Care........................ Diclofenac 0.1% Solution,
Dorzolamide 2%/Timolol
0.5% Solution,
Latanoprost 0.005%
Solution, PEG-400 0.4%/
Propylene Glycol 0.3%
Solution.
Heart Health and Blood Pressure.............. Amlodipine Tablet,
Amiodarone HCL Tablet,
Aspirin (see Arthritis
and Pain), Atenolol
Tablet, Benazepril
Tablet, Carvedilol
Tablet, Chlorthalidone
Tablet, Clonidine
Tablet, Diltiazem 24-
hour Capsule, Diltiazem
HCL Tablet, Enalapril
Maleate Tablet,
Furosemide Tablet,
Hydrochlorothiazide
Capsule/Tablet,
Hydrochlorothiazide/
Lisinopril Tablet,
Hydrochlorothiazide/
Losartan Tablet,
Hydrochlorothiazide/
Triamterene Capsule/
Tablet, Isosorbide
Mononitrate SA Tablet,
Lisinopril Tablet,
Losartan Tablet,
Metoprolol Succinate SA
Tablet, Metoprolol
Tartrate Tablet,
Nifedipine SA Tablet,
Nitroglycerin Sublingual
Tablet, Prazosin HCL
Capsule, Propranolol HCL
Tablet, Spironolactone
Tablet, Verapamil HCL
Tablet, Verapamil HCL SA
Tablet.
Mental Health................................ Amitriptyline HCL Tablet,
Bupropion HCL Tablet,
Bupropion HCL SA (12HR-
SR) Tablet, Bupropion
HCL SA (24HR-XL) Tablet,
Citalopram Hydrobromide
Tablet, Duloxetine HCL
EC Capsule, Escitalopram
Oxalate Tablet,
Fluoxetine Capsule/
Tablet, Lithium
Carbonate Capsule/
Tablet, Mirtazapine
Tablet, Paroxetine HCL
Tablet, Sertraline HCL
Tablet, Trazodone
Tablet.
Respiratory Condition........................ Montelukast NA Tablet.
Seizures..................................... Gabapentin Capsule/
Tablet, Lamotrigine
Tablet, Topiramate
Tablet.
Thyroid Conditions........................... Levothyroxine Sodium
Tablet.
Urologic (Bladder and Prostate) Health....... Alfuzosin HCL SA Tablet,
Doxazosin Mesylate
Tablet, Finasteride
Tablet, Sildenafil
Tablet, Tamsulosin HCL
Capsule, Terazosin HCL
Capsule.
------------------------------------------------------------------------
Signing Authority
The Secretary of Veterans Affairs, or designee, approved this
document and authorized the undersigned to sign and submit the document
to the Office of the Federal Register for publication electronically as
an official document of the Department of Veterans Affairs. Pamela
Powers, Chief of Staff, Department of Veterans Affairs, approved this
document on February 19, 2020, for publication.
Luvenia Potts,
Regulation Development Coordinator, Office of Regulation Policy &
Management, Office of the Secretary, Department of Veterans Affairs.
[FR Doc. 2020-03834 Filed 2-26-20; 8:45 am]
BILLING CODE 8320-01-P